Kwality Pharmaceuticals Limited (BOM:539997)

Market Cap	12.08B
Revenue (ttm)	3.70B
Net Income (ttm)	398.45M
Shares Out	10.38M
EPS (ttm)	38.36
PE Ratio	30.36
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,327
Average Volume	29,642
Open	1,188.95
Previous Close	1,164.60
Day's Range	1,157.10 - 1,208.00
52-Week Range	483.10 - 1,235.00
Beta	-0.22
RSI	63.61
Earnings Date	Aug 7, 2025

About Kwality Pharmaceuticals

Kwality Pharmaceuticals Limited, together with its subsidiary, manufactures, buys, sells, and deals finished pharmaceutical formulations in India and internationally. It offers its products in various dosage forms, including liquid orals, powder for oral suspension, tablets, capsules, sterile powder for injections, small volume injectables, ointments/cream, external preparations, ORS, eye/ear drops, sanitizers, suppositories, injectable vials and ampoules, lyophilized and covid products, syrups, daunorubicin, and other various categories, such ...

• Industry: Pharmaceutical Preparations
• Founded: 1983
• Employees: 806
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 539997

Financial Performance

In 2024, Kwality Pharmaceuticals's revenue was 3.70 billion, an increase of 20.52% compared to the previous year's 3.07 billion. Earnings were 398.45 million, an increase of 67.44%.